Caris Life Sciences
Business Services · Texas, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
750 W John Carpenter Fwy Ste 800, Irving...Phone Number
(866) 771-8946Website
www.carislifesciences.comRevenue
$907.3 MillionStock Symbol
CAIIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
5
2
8
2
2
About Caris Life Sciences
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.Explore more
Caris Life Sciences Org Chart
SM
Senior Vice President
TM
Vice President, Clinical Programs
SS
Vice President, Operations
MD
Corporate Vice President - Oncology Franchise
CB
Corporate Vice President, Strategy & Operatio...
RK
Head Vice President, Diagnostic Partnering, P...
JX
Vice President, Clinical & Translational Rese...
NL
Vice President, Facilities
BS
Vice President, Corporate, Clinical Software ...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caris Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Caris Life Sciences recently announced quarterly report
Caris Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Caris Life Sciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Caris Life Sciences had a recent Job posting/layoffs
Product Launch: Get notified when Caris Life Sciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Caris Life Sciences
Funding: Get notified immidiatlly once Caris Life Sciences has new funding data
Check if Caris Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Caris Life Sciences
Compare insights from companies similar to Caris Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
$161.2M
501-1,000
Private
-
1996
Anuradha SinghalSenior Vice President, Chief Marketing Officer, Senior Laboratory Medical Director
Company Profile Activity
Activity Insights
Caris Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caris Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caris Life Sciences.
Caris Life Sciences financials insights
Gather financial insights about Caris Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Unspecified
$150M
2020
Unspecified
$310M
2021
Other Financing Round
$830M
2023
Debt
$400M
2025
Other Financing Round
$168M
IPO
$494M
2026
Debt
$1.2B
Caris Life Sciences Tech Stack
A closer look at the technologies used by Caris Life Sciences
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Caris Life Sciences News & Media
Caris Life Sciences Announces Share Repurchase Program
IRVING, Texas, June 8, 2026 /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that its Board of Directors has authorized a share repurchase program for up to $100...Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
Inaugural story spotlights a woman whose presumed stage 4 metastatic breast cancer diagnosis was corrected by Caris GPSai, an AI-powered tissue-of-origin model, revealing a highly treatable lymphoma IRVING, Texas, May 26, 2026 /PRNewswire/ -- Caris Life Sciences®, Inc. (NASDAQ: CAI), a...You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees.
Caris Life Sciences just earned a $33.87 million vote of confidence from Stanley Druckenmiller, and most people completely missed it.Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
The Caris Lookback Program identified 13,293 patients potentially eligible for newly approved targeted therapies across 10 tumor types IRVING, Texas, May 15, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Caris Life Sciences
Sign Up For FreeTo access detailed company insights
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.... Read More
